Novo Nordisk A/S
NVO
$81.18
-$3.44-4.07%
| Weiss Ratings | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Reward Grade | B | |||
| Rating Factors | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Excellent | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.49 | |||
| Price History | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -7.24% | |||
| 30-Day Total Return | -23.51% | |||
| 60-Day Total Return | -31.22% | |||
| 90-Day Total Return | -39.66% | |||
| Year to Date Total Return | -7.24% | |||
| 1-Year Total Return | -23.07% | |||
| 2-Year Total Return | 18.81% | |||
| 3-Year Total Return | 73.22% | |||
| 5-Year Total Return | 188.34% | |||
| 52-Week High % Change | -42.88% | |||
| 52-Week Low % Change | 3.83% | |||
| Price | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $148.15 | |||
| 52-Week Low Price | $81.50 | |||
| 52-Week Low Price (Date) | Dec 20, 2024 | |||
| 52-Week High Price (Date) | Jun 25, 2024 | |||
| Valuation | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 372.55B | |||
| Enterprise Value | 370.10B | |||
| Price/Earnings (TTM) | 27.43 | |||
| Earnings Per Share (TTM) | 3.09 | |||
| Earnings Per Share Growth | 28.16% | |||
| Price/Earnings To Growth | 0.97 | |||
| Price/Sales (TTM) | 9.59 | |||
| Price/Book (Q) | 20.90 | |||
| Enterprise Value/Revenue (TTM) | 9.40 | |||
| Price | $81.18 | |||
| Enterprise Value/EBITDA (TTM) | 18.83 | |||
| Enterprise Value/EBIT | 20.28 | |||
| Market Cap Category | Mega Cap | |||
| Dividends and Shares | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 4.46B | |||
| Dividend Yield | 1.21% | |||
| Div. Per Share (Most Recent) | $0.36 | |||
| Dividend Per Share (TTM) | $1.03 | |||
| Payout Ratio (TTM) | 46.82% | |||
| Dividend Per Share (Most Recent) | $0.36 | |||
| Company Info | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 45 44 44 88 88 | |||
| Address | -- | |||
| Website | www.novonordisk.com | |||
| Country | Denmark | |||
| Year Founded | 1923 | |||
| Profitability | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 46.38% | |||
| Profit Margin | 35.03% | |||
| Management Effectiveness | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 22.37% | |||
| Return on Equity | 88.33% | |||
| Income Statement | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 39.35B | |||
| Total Revenue (TTM) | 39.35B | |||
| Revenue Per Share | $8.82 | |||
| Gross Profit (TTM) | 33.31B | |||
| EBITDA (TTM) | 19.66B | |||
| EBIT (TTM) | 18.25B | |||
| Net Income (TTM) | 13.79B | |||
| Net Income Avl. to Common (TTM) | 13.79B | |||
| Total Revenue Growth (Q YOY) | 22.51% | |||
| Earnings Growth (Q YOY) | 22.55% | |||
| EPS Diluted (TTM) | 3.09 | |||
| EPS Diluted Growth (Q YOY) | 23.50% | |||
| Balance Sheet | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 11.20B | |||
| Cash Per Share (Q) | $2.51 | |||
| Total Current Assets (Q) | 29.19B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 18.03B | |||
| Current Ratio (Q) | 0.937 | |||
| Book Value Per Share (Q) | $4.05 | |||
| Total Assets (Q) | 59.44B | |||
| Total Current Liabilities (Q) | 31.16B | |||
| Total Debt (Q) | 8.52B | |||
| Total Liabilities (Q) | 41.42B | |||
| Total Common Equity (Q) | 18.03B | |||
| Cash Flow | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -7.62B | |||
| Cash from Financing (TTM) | -5.61B | |||
| Net Change in Cash (TTM) | 3.92B | |||
| Levered Free Cash Flow (TTM) | 7.13B | |||
| Cash from Operations (TTM) | 17.21B | |||
